| 1 |
Vitiligo-specific soluble biomarkers as early indicators of response to immune checkpoint inhibitors in metastatic melanoma patients |
|
|
| Maria Luigia Carbone, Gabriele Madonna, Alessia Capone, Marianna Bove, Simona Mastroeni, Lauretta Levati, Mariaelena Capone, Paolo Antonio Ascierto, Federica De Galitiis, Stefania D’Atri, Cristina Fortes, Elisabetta Volpe, Cristina Maria Failla |
|
| Scientific Reports. 2022; 12(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Differentiating active from stable vitiligo: The role of dermoscopic findings and their relation to CXCL10 |
|
|
| Sarah Ibrahim, Rehab A. Hegazy, Heba I. Gawdat, Samia Esmat, Esraa Mahmoud, Laila Rashed, Amira Aly Hegazy, Dina G. Saadi |
|
| Journal of Cosmetic Dermatology. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Sensitivity of serum S100B protein as a disease activity marker in Egyptian patients with vitiligo (case-control study) |
|
|
| Fatma H. Shabaka, Laila A. Rashed, Marwa Said, Lobna Ibrahim |
|
| Archives of Physiology and Biochemistry. 2020; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Consensus on the treatment of vitiligo – Brazilian Society of Dermatology |
|
|
| Gerson Dellatorre, Daniela Alves Pereira Antelo, Roberta Buense Bedrikow, Tania Ferreira Cestari, Ivonise Follador, Daniel Gontijo Ramos, Caio Cesar Silva de Castro |
|
| Anais Brasileiros de Dermatologia. 2020; 95: 70 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
The impact of NBUVB on microbial community profiling in the lesional skin of vitiligo subjects |
|
|
| Xiangfeng Yuan, Linlin Wang, Dan Meng, Lingyun Wu, Xing Wang, Dong Zhang, Zengxiang Luo, Yunyan Pang, Guoyan Liu |
|
| Microbial Pathogenesis. 2020; 140: 103943 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Vitiligo, an ancient but still enigmatic disease |
|
|
| Mohamed Badawy Abdel-Naser |
|
| Edorium Journal of Dermatology. 2015; 1(1): 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
